Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADAM17 | P78536 | 2/20 | 0.52 |
| ▸ | MMP2 | P08253 | 14/20 | 0.43 |
| ▸ | MMP3 | P08254 | 14/20 | 0.43 |
| ▸ | MMP7 | P09237 | 12/20 | 0.43 |
| ▸ | MMP1 | P03956 | 11/20 | 0.43 |
| ▸ | MMP8 | P22894 | 3/20 | 0.43 |
| ▸ | MMP9 | P14780 | 2/20 | 0.43 |
| ▸ | MMP13 | P45452 | 2/20 | 0.43 |
| ▸ | MMP12 | P39900 | 1/20 | 0.43 |
| ▸ | MMP14 | P50281 | 1/20 | 0.43 |
| ▸ | APP | P05067 | 1/20 | 0.42 |
| ▸ | FCER2 | P06734 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7848057 | 1.00 | ADAM17 (0.52) | ADAM17MMP2MMP3MMP7MMP1 | |
| SCHEMBL7846628 | 0.89 | ADAM17 (0.42) | ADAM17MMP2MMP3MMP7MMP1 | |
| SCHEMBL7846625 | 0.89 | ADAM17 (0.42) | ADAM17MMP2MMP3MMP7MMP1 | |
| SCHEMBL7837789 | 0.89 | ADAM17 (0.42) | ADAM17MMP2MMP3MMP7MMP1 | |
| SCHEMBL7837792 | 0.89 | ADAM17 (0.42) | ADAM17MMP2MMP3MMP7MMP1 | |
| SCHEMBL7840861 | 0.84 | MMP1 (0.47) | ADAM17MMP2MMP3MMP7MMP1 | |
| SCHEMBL7846497 | 0.84 | MMP1 (0.47) | ADAM17MMP2MMP3MMP7MMP1 | |
| SCHEMBL6945072 | 0.83 | ADAM17 (0.58) | ADAM17MMP2MMP3MMP7MMP1 | |
| SCHEMBL6945099 | 0.83 | ADAM17 (0.58) | ADAM17MMP2MMP3MMP7MMP1 | |
| SCHEMBL6945094 | 0.83 | ADAM17 (0.58) | ADAM17MMP2MMP3MMP7MMP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1137640-A1 | CYCLIC HYDRAZINE DERIVATIVES AS TNF-ALPHA INHIBITORS | F. HOFFMANN-LA ROCHE AG (CH) | 2001-10-04 | — | — | EP | disclosed |
| US-6281363-B1 | ANTIINFLAMMATORY AGENTS; ANTIARTHRITIC AGENTS; AUTOIMMUNE DISORDERS | HOFFMANN-LA ROCHE INC. | 2001-08-28 | — | — | US | disclosed |
| WO-2000035885-A1 | CYCLIC HYDRAZINE DERIVATIVES AS TNF-ALPHA INHIBITORS | F. HOFFMANN-LA ROCHE AG (CH) | 2000-06-22 | — | — | WO | disclosed |